Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ilepatril

Known as: (4S,7S,12BR)-7-((2S)-2-(Acetylsulfanyl)-3-Methylbutanamido)-6-Oxo-1,2,3,4,6,7,8,12b-Octahydropyrido(2,1-A)(2)Benzazepine-4-Carboxylic Acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Objective: The aim of the present study was to compare the preventive impact of treatment with a vasopeptidase inhibitor… Expand
Highly Cited
2012
Highly Cited
2012
PURPOSE Cornea confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2012
2012
Treating high fat fed/low dose streptozotocin-diabetic rats; model of type 2 diabetes, with ilepatril (vasopeptidase inhibitor… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2012
2012
We have demonstrated that treating diet-induced obese (DIO) mice with the vasopeptidase inhibitor ilepatril improved neural… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
2012
2012
  • N. Efron
  • Investigative ophthalmology & visual science
  • 2012
  • Corpus ID: 11779516
N europathy is a frequent complication of diabetes and is a major cause of morbidity and mortality, potentially affecting distal… Expand
2011
2011
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril… Expand
2011
2011
Previously we demonstrated that inhibition of neutral endopeptidase (NEP), a protease that degrades vaso- and neuro-active… Expand
2011
2011
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril… Expand
Review
2008
Review
2008
  • R. Tabrizchi
  • Current opinion in investigational drugs
  • 2008
  • Corpus ID: 11705565
sanofi-aventis (formerly Aventis Pharma AG) is developing ilepatril (AVE-7688), a dual angiotensin-converting enzyme and neutral… Expand